IBItzhak Binderman

Itzhak Binderman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Itzhak Binderman has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    3D‐Printed Titanium Implants with Bioactive Peptide‐Polysaccharide Scaffolds for Personalized Bone Reconstruction

    by Noam Rattner, Vladimir Perlis, Eran Golden, Ariel Pokhojaev, Rachel Sarig, Itzhak Binderman, Michal Halperin‐Sternfeld, Solomon Dadia, Lihi Adler‐Abramovich

    Large bone defects caused by trauma, tumor resection, or congenital abnormalities remain a major clinical challenge. Standard titanium implants are widely used due to their strength and biocompatibility, but their bioinert surfaces often lead to poor osseointegration. The emergence of 3D printing has enabled patient‐specific titanium implants with tailored architecture and mechanical properties. However, these constructs still lack the bioactivity required for robust and spatially uniform bone integration, particularly within the implant core. To address this limitation, we developed a bioactive, cell‐free strategy that integrates porous titanium implants with a nanofibrillar peptide‐hyaluronic acid scaffold, delivered either as a hydrogel or in lyophilized form. The scaffold exhibited enhanced enzymatic stability and supported osteoblast‐like cell adhesion in vitro. In a rabbit calvarial critical‐size bone defect model, scaffold‐integrated implants significantly outperformed inert controls, with hydrogel integration nearly doubling inner bone volume and improving trabecular architecture. Histological analysis confirmed enhanced bone‐implant integration, active periosteum, healthy marrow, and reduced inflammation. This acellular, growth‐factor‐free approach combines the structural precision of titanium with the regenerative potential of ECM‐mimicking scaffolds, offering a translatable pathway for personalized skeletal repair.


  • Open Access

    3D-Printed Titanium Implants with Bioactive Peptide-polysaccharide Scaffolds for Personalized Bone Reconstruction

    by Noam Rattner, Vladimir Perlis, Eran Golden, Ariel Pokhojaev, Rachel Sarig, Itzhak Binderman, Michal Halperin-Sternfeld, Solomon Dadia, Lihi Adler-Abramovich

    Large bone defects caused by trauma, tumor resection, or congenital abnormalities remain a major clinical challenge. Standard titanium implants are widely used due to their strength and biocompatibility, but their bioinert surfaces often lead to poor osseointegration. The emergence of 3D printing has enabled patient-specific titanium implants with tailored architecture and mechanical properties. However, these constructs still lack the bioactivity required for robust and spatially uniform bone integration, particularly within the implant core. To address this limitation, we developed a bioactive, cell-free strategy that integrates porous titanium implants with a nanofibrillar peptide-hyaluronic acid scaffold, delivered either as a hydrogel or in lyophilized form. The scaffold exhibited enhanced enzymatic stability and supported osteoblast-like cell adhesion in vitro . In a rabbit calvarial critical-size bone defect model, scaffold-integrated implants significantly outperformed inert controls, with hydrogel integration nearly doubling inner bone volume and improving trabecular architecture. Histological analysis confirmed enhanced bone-implant integration, active periosteum, healthy marrow, and reduced inflammation. This acellular, growth-factor-free approach combines the structural precision of titanium with the regenerative potential of ECM-mimicking scaffolds, offering a translatable pathway for personalized skeletal repair.

  • Open Access

    The Immunobiological and Dense Collagen Fibrous Connective Tissue Barriers: The Gate to Periodontal and Peri-Implant Health and Longevity

    by Itzhak Binderman, Michal Halperin-Sternfeld, Alberto Miselli

    Periodontal disease is the primary cause of alveolar bone loss and tooth loss, with pathogenesis rooted in microbial invasion and immune dysregulation. Despite advances in periodontal therapy and implantology, peri-implantitis has emerged as a significant clinical challenge due to the absence of natural protective barriers around implants. This chapter explores the structural and immunobiological roles of two key periodontal defense systems: the supracrestal gingival tissue (SGT) and the periodontal organ (PO). The PO’s fibrous barrier, comprising collagen fibers and mechanically strained fibroblasts, is critical for maintaining periodontal health. Its degradation, mediated mainly by matrix metalloproteinases (MMPs), leads to compromised mechanical integrity, dysfunction of fibroblasts, adenosine triphosphate (ATP) release, and inflammatory bone resorption. In contrast, peri-implant tissues lack this organized fibrous attachment, relying instead on a vulnerable epithelial interface, making them highly susceptible to peri-implantitis. We describe novel strategies to mimic the fibrous attachment of natural dentition by bioengineering periosteal integration onto implant abutments. Additionally, we highlight emerging therapeutic approaches, including MMP inhibition and purinergic receptor blockade, to preserve soft tissue barriers and prevent bone loss. Overall, maintaining the structural and mechanobiological integrity of SGT and PO is essential for both periodontal and peri-implant health. Future therapies must target both the microbial and molecular pathways that compromise these barriers.

  • Open Access

    Stable, Easy‐to‐Handle, Fully Autologous Electrospun Polymer‐Peptide Skin Equivalent for Severe Burn Injuries

    by Dana Cohen‐Gerassi, Marina BenShoshan, Adi Liiani, Tomer Reuveni, Offir Loboda, Moti Harats, Josef Haik, Itzhak Binderman, Yosi Shacham‐Diamand, Amit Sitt, et al.

    Severe burn injuries represent a significant clinical challenge due to their complex healing process and the high risk of complications, including infection, scarring, and contracture formation. Current therapeutic approaches for burn wound treatment include autologous donor‐site grafting and advanced cell therapy techniques like cultured epidermal autografts (CEA), which successfully facilitate wound closure through re‐epithelialization. However, CEAs are limited by fragility, shrinkage, lack of a dermal layer, and risks of contamination. Here, aiming to overcome these limitations, this work develops a personalized skin equivalent featuring an engineered scaffold composed of electrospun poly(ε‐caprolactone) (PCL) functionalized with the bioactive peptide fluorenylmethyloxycarbonyl‐phenylalanine‐arginine‐glycine‐aspartic acid (Fmoc‐FRGD). This scaffold is designed to mimic the natural extracellular matrix (ECM), promoting cellular adhesion, integration, and proliferation while maintaining structural integrity. In vitro analysis demonstrated the scaffold's ability to support multi‐layered human skin cell growth, while in vivo experiments confirmed its efficacy in facilitating wound closure and full‐thickness skin regeneration in a murine model. This bioengineered skin equivalent is mechanically robust, easy to handle, fully autologous and exhibits no contraction, offering a transformative therapeutic alternative for the treatment of severe burn injuries.


  • Open Access

    Stable, Easy-to-Handle, Fully Autologous Electrospun Polymer-Peptide Skin Equivalent for Severe Burn Injuries

    by Dana Cohen-Gerassi, Marina BenShoshan, Adi Liiani, Tomer Reuveni, Offir Loboda, Moti Haratz, Josef Haik, Itzhak Binderman, Yosi Shacham-Diamand, Amit Sitt, et al.

    Severe burn injuries represent a significant clinical challenge due to their complex healing process and the high risk of complications, including infection, scarring, and contracture formation. Current therapeutic approaches for burn wound treatment include autologous donor-site grafting and advanced cell therapy techniques like cultured epidermal autografts (CEA), which successfully facilitate wound closure through re-epithelialization. However, CEAs are limited by fragility, shrinkage, lack of a dermal layer, and risks of contamination. Here, aiming to overcome these limitations, we developed a personalized skin equivalent featuring an engineered scaffold composed of electrospun polycaprolactone (PCL) functionalized with the bioactive peptide fluorenylmethyloxycarbonyl-phenylalanine-arginine-glycine-aspartic acid (Fmoc-FRGD). This scaffold is designed to mimic the natural extracellular matrix (ECM), promoting cellular adhesion, integration, and proliferation while maintaining structural integrity. In-vitro analysis demonstrated the scaffold’s ability to support multi-layered human skin cell growth, while in-vivo experiments confirmed its efficacy in facilitating wound closure and full-thickness skin regeneration in a murine model. This bioengineered skin equivalent is mechanically robust, easy to handle, fully autologous and exhibits no contraction, offering a transformative therapeutic alternative for the treatment of severe burn injuries.


  • Open Access

    Quantitative MR Analysis of Changes in the Radius Bone Marrow in Osteoporosis

    by Tamar K. De-Levie, Yael S. Schiffenbauer, Ido Druckmann, Vanessa Rouach, Naftali Stern, Itzhak Binderman, Uri Nevo

    Purpose. This pilot study aimed to explore the feasibility of scanning the human distal radius bone marrow in vivo to detect osteoporosis-related changes using magnetic resonance and evaluate whether the radius may serve as an accessible probing site for osteoporosis. This may lead in the future to the use of affordable means such as low-field MRI scanners for the monitoring of disease progression. Methods. A clinical trial was performed using a 3T MR scanner, including 26 women assigned into three study groups: healthy-premenopausal (n=7; mean age 48.63.5years), healthy-postmenopausal (n=10; mean age 54.55.6years), and osteoporotic-postmenopausal (n=9; mean age 61.35.6years). Marrow fat composition was evaluated using T2 maps, a two-compartment model of T1, and a Dixon pulse sequence. Results. The osteoporotic group exhibited higher fat content than the other two groups and lower T2 values than the healthy-premenopausal group. Conclusions. Osteoporosis-related changes in the composition of the distal radius bone marrow may be detected in vivo using MRI protocols. The scanning protocols chosen here can later be repeated using low-field MRI scanners, thus offering the potential for early detection and treatment monitoring, using an accessible, affordable means that may be applied in small clinics. This trial is registered with MOH_2018-05-23_002247, NCT03742362.

  • Open Access

    Immunomodulatory fibrous hyaluronic acid‐Fmoc‐diphenylalanine‐based hydrogel induces bone regeneration

    by Michal Halperin‐Sternfeld, Ariel Pokhojaev, Moumita Ghosh, Dana Rachmiel, Raha Kannan, Itzhak Grinberg, Moshe Asher, Moran Aviv, Peter X. Ma, Itzhak Binderman, et al.

    Aim: To investigate the potential of an ultrashort aromatic peptide hydrogelator integrated with hyaluronic acid (HA) to serve as a scaffold for bone regeneration.Materials and Methods: Fluorenylmethyloxycarbonyl‐diphenylalanine (FmocFF)/HA hydrogel was prepared and characterized using microscopy and rheology. Osteogenic differentiation of MC3T3‐E1 preosteoblasts was investigated using Alizarin red, alkaline phosphatase and calcium deposition assays. In vivo, 5‐mm‐diameter calvarial critical‐sized defects were prepared in 20 Sprague–Dawley rats and filled with either FmocFF/HA hydrogel, deproteinized bovine bone mineral, FmocFF/Alginate hydrogel or left unfilled. Eight weeks after implantation, histology and micro‐computed tomography analyses were performed. Immunohistochemistry was performed in six rats to assess the hydrogel's immunomodulatory effect.Results: A nanofibrous FmocFF/HA hydrogel with a high storage modulus of 46 KPa was prepared. It supported osteogenic differentiation of MC3T3‐E1 preosteoblasts and facilitated calcium deposition. In vivo, the hydrogel implantation resulted in approximately 93% bone restoration. It induced bone deposition not only around the margins, but also generated bony islets along the defect. Elongated M2 macrophages lining at the periosteum–hydrogel interface were observed 1 week after implantation. After 3 weeks, these macrophages were dispersed through the regenerating tissue surrounding the newly formed bone.Conclusions: FmocFF/HA hydrogel can serve as a cell‐free, biomimetic, immunomodulatory scaffold for bone regeneration.


  • The effects of mechanical loading on hard and soft tissues and cells

    by Itzhak Binderman, Lital Young, Hila Bahar, Nasser Gadban, Avinoam Yaffe


  • Cytoskeletal disease: a role in the etiology of adult periodontitis

    by I Binderman, N Gadban, A Yaffe

    All cells and organisms across the evolutionary spectrum, from the most primitive to the most complex, are mechanosensitive. As the cytoskeleton is a key in controlling the normal basal prestress of cells and therefore is involved in virtually all physiological cellular processes, abnormalities in this essential cellular characteristic may result in diseases. Indeed, many diseases have now been associated with abnormalities in cytoskeletal and nucleoskeletal proteins. We propose that adult periodontitis is, at least in part, such a cytoskeletal disease. It is well established that adult periodontitis starts by bacterial invasion at the interface between the tooth surface and marginal gingiva that induces a local inflammatory response. The inflammatory cells release metalloproteinases which degrade gingival collagenous fibrous tissue and loss of local tissue integrity that reduces the normal prestressed cell-extracellular matrix network. This is a major signaling trigger that induces a local and rapid release of ATP, which then activates P2X receptors and stimulates a calcium influx, further activating osteoclastic resorption of the alveolar bone. As periodontitis is a chronic disease, it seems reasonable to suggest that agents that maintain cytoskeletal tensegrity, for example, inhibitors of ATP receptors, may diminish the bone loss and may have a role in future periodontal therapy.